-

ALERT: Rowley Law PLLC is Investigating Potential Breaches of Fiduciary Duty by Officers and Directors of Regeneron Pharmaceuticals, Inc.

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential claims for breach of fiduciary duty involving the directors and officers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN).

If you are a stockholder of Regeneron Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/regn/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Shane Rowley, Esq.
Rowley Law PLLC
50 Main Street Suite 1000
White Plains, NY 10606
info@rowleylawpllc.com
914-400-1920
844-400-4643 (toll-free)

Industry:

Rowley Law PLLC

NASDAQ:REGN
Release Versions
English

Contacts

Shane Rowley, Esq.
Rowley Law PLLC
50 Main Street Suite 1000
White Plains, NY 10606
info@rowleylawpllc.com
914-400-1920
844-400-4643 (toll-free)

More News From Rowley Law PLLC

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapeutics, Inc.

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by Aimmune Therapeutics, Inc. (NASDAQ: AIMT) and its board of directors concerning the proposed acquisition of the company by Nestlé S.A. Stockholders will receive $34.50 in cash for each share of Aimmune Therapeutics stock that they hold. The transaction is valued at approximately $2.6 billion and is expected to close in the fourth quarter of 2020. If you are a stockholder of Aimmune Therapeutics, I...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BMC Stock Holdings, Inc.

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by BMC Stock Holdings, Inc. (NASDAQ: BMCH) and its board of directors concerning the proposed acquisition of the company by Builders FirstSource, Inc. (NASDAQ: BLDR). Stockholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC Stock Holdings stock that they hold. The transaction is expected to close in late 2020 or early 2021. If you are a stockholder of BMC Sto...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Proteostasis Therapeutics, Inc.

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by Proteostasis Therapeutics, Inc. (NASDAQ: PTI) and its board of directors concerning the proposed acquisition of the company by Yumanity Therapeutics. Proteostasis Therapeutics stockholders will own approximately 32.5% of the combined company. The transaction is expected to close in the fourth quarter of 2020. If you are a stockholder of Proteostasis Therapeutics, Inc. and are interested in obtaini...
Back to Newsroom